ClinicalTrials.gg
Drug

Belinostat clinical trials

Also written PXD101 and Beleodaq.

studies test it
48
open now
1
in phase 3
1
first study started
2005

How each study uses belinostat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the belinostat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
3 Jul 2014 · BELEODAQ · NDA 206256 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Belinostat
36

Brand

Beleodaq
14

Development codes

PXD101
28

In one entry with another drug

Given together, or one or the other

Belinostat, Carboplatin, Paclitaxel
2

Studies by the year they started

48 studies that test it; most in 2006 (12)

Studies that test belinostat, by start year
YearStudies
20053
200612
20073
20081
20093
20105
20111
20121
20132
20142
20151
20165
20191
20201
20213
20221
20232
20261

Who runs them

Industry 17 · Other 31

National Cancer Institute (NCI) (16) · Valerio Therapeutics (9) · Acrotech Biopharma Inc. (6) · University of Utah (3) · Spectrum Pharmaceuticals, Inc (2) · M.D. Anderson Cancer Center (2) · H. Lee Moffitt Cancer Center and Research Institute (1) · Emory University (1)

Often tested with

Tested in the same studies.

Carboplatin (2) · Paclitaxel (2) · Tazemetostat (1) · Pralatrexate (1) · Cyclophosphamide (1) · Doxorubicin (1) · Vincristine (1) · Prednisone (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Belinostat is the comparator. A study of two new drugs counts under both.

  • 1Soquelitinib · Corvus Pharmaceuticals, Inc. · next primary completion Nov 2027
Reaching primary completion within a year · 2

Studies that test belinostat.

Studies

Open first, then newest update. How each study uses belinostat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 48

See all 48 studies that test belinostat →

Given beside what is tested · 5 — belinostat is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with belinostat

What changed recently

From the registry's own updates since Oct 20, 2026.

Results posted1

Codes

What other systems call belinostat · ClinicalTrials.gg INT004656

  • MeSH (NLM) C487081belinostatConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) F4H96P17NZBELINOSTATConfirmed FDA, NLM, Wikidata
  • RxNorm 1543543Confirmed FDA, Wikidata
  • Wikidata Q4882925belinostatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C48812BelinostatConfirmed FDA, Wikidata
  • DrugBank DB05015One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.